Date | Company Name | Details |
---|---|---|
31-Jul-2025 | Chemo Pharma Lab | Chemo Pharma Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2025 ,inter alia, to consider and approve 1. To consider and accept resignation of existing statutory auditors. 2. To appoint fresh statutory auditors to fill the casual vacancy cause due to resignation of existing statutory auditor. |
31-Jul-2025 | IVP | IVP Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2025 inter alia to consider and approve unaudited financial results for the quarter ended Jun 30 2025 |
31-Jul-2025 | Gillette India | Gillette India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2025 inter alia to consider and approve unaudited financial results for the quarter ended June 302025 |
31-Jul-2025 | Nexome Cap. Mkt. | Nexome Capital Markets Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2025 inter alia to consider and approve 1. Un-audited Financial Results for the quarter ended June 30 2025. 2. Raising of funds pursuant to an issue of equity shares of the Company with a face value of ? 10 each (the Equity Shares) by way of a Rights Issue to the eligible equity shareholders of the Company subject to the receipt of applicable regulatory/statutory approvals as may be required. 3. Any other matter if required with the permission of the chair. |
31-Jul-2025 | Cholaman.Inv.&Fn | Cholamandalam Investment And Finance Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2025 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results for the quarter ended 30 June 2025. |